Q4 2023 Holdings
Filed 2024-02-14 | 29 holdings | $901.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Structure Therapeutics Inc(GPCR) | ADRS | 86366E106 | $86.0M | 2,109,584 | 9.5% |
| Inhibrx,inc(INBXUSD) | COMM | 45720L107 | $66.5M | 1,750,387 | 7.4% |
| Icosavax Inc | COMM | 45114M109 | $58.4M | 3,703,704 | 6.5% |
| An2 Therapeutics, Inc.(ANTX) | COMM | 037326105 | $54.9M | 2,678,209 | 6.1% |
| Rayzebio, Inc. | COMM | 75525N107 | $54.1M | 869,908 | 6.0% |
| Aerovate Therapeutics Inc | COMM | 008064107 | $49.8M | 2,201,274 | 5.5% |
| Geron Corp(GERN) | COMM | 374163103 | $49.3M | 23,375,839 | 5.5% |
| Savara Inc.(SVRA) | COMM | 805111101 | $47.0M | 10,000,000 | 5.2% |
| Gracell Biotechnologies Inc. | ADRS | 38406L103 | $45.3M | 4,514,786 | 5.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COMM | 558868105 | $41.6M | 179,917 | 4.6% |
| Kalvista Pharmaceuticals, Inc(KALV) | COMM | 483497103 | $41.6M | 3,395,495 | 4.6% |
| Silence Therapeutics PLC(SLN) | ADRS | 82686Q101 | $36.6M | 2,104,875 | 4.1% |
| Compass Pathways PLC(CMPS) | ADRS | 20451W101 | $33.8M | 3,858,000 | 3.7% |
| Cogent Biosciences Inc(COGT) | COMM | 19240Q201 | $33.1M | 5,631,042 | 3.7% |
| Tyra Biosciences Inc(TYRA) | COMM | 90240B106 | $27.5M | 1,989,103 | 3.1% |
| Tourmaline BIO Inc(TRML) | COMM | 89157D105 | $26.4M | 1,007,902 | 2.9% |
| Tarsus Pharmaceuticals, Inc.(TARS) | COMM | 87650L103 | $23.1M | 1,142,857 | 2.6% |
| Dyne Therapeutics, Inc(DYN) | COMM | 26818M108 | $21.9M | 1,650,150 | 2.4% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $20.5M | 1,423,642 | 2.3% |
| Centessa Pharmaceuticals PLC(CNTA) | COMM | 152309100 | $16.2M | 2,040,816 | 1.8% |
| Vistagen Therapeutics Inc(VTGNUSD) | COMM | 92840H202 | $13.8M | 2,676,580 | 1.5% |
| Abivax SA(ABVX) | COMM | 00370M103 | $11.8M | 1,100,000 | 1.3% |
| Cabaletta BIO, Inc(CABA) | COMM | 12674W109 | $11.1M | 486,795 | 1.2% |
| Entrada Therapeutics Inc(TRDA) | COMM | 29384C108 | $8.8M | 584,955 | 1.0% |
| Nurix Therapeutics Inc(NRIX) | COMM | 67080M103 | $7.4M | 717,654 | 0.8% |
| C4 Therapeutics, Inc.(CCCC) | COMM | 12529R107 | $7.2M | 1,276,574 | 0.8% |
| Taysha Gene Therapies, Inc.(TSHA) | COMM | 877619106 | $5.2M | 2,912,861 | 0.6% |
| Ventyx Biosciences, Inc(VTYX) | COMM | 92332V107 | $2.0M | 815,724 | 0.2% |
| Kodiak Sciences Inc(KOD) | COMM | 50015M109 | $814.5K | 267,941 | 0.1% |